Cargando…
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
SIMPLE SUMMARY: Dedifferentiated chondrosarcoma is a rare type of cancer that is very aggressive and has a poor prognosis with poor survival rates. This disease can affect anyone of any age, but it is usually diagnosed among people 50 years of age or older. There is no standard treatment available;...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417069/ https://www.ncbi.nlm.nih.gov/pubmed/37568740 http://dx.doi.org/10.3390/cancers15153924 |